Abstract
The new thiazolyl peptide antibiotic GE2270 A, isolated from Planobispora rosea strain ATCC 53773, is shown to inhibit bacterial protein biosynthesis in vitro by affecting specifically the GTP-bound form of elongation factor Tu (EF-Tu). The 'off' rate of EF-Tu.GTP is slowed down 400-fold, locking GTP on EF-Tu, whereas EF-Tu.GDP is unaffected. Therefore, on the EF-Tu.guanine nucleotide interaction, GE2270 A mimicks the effect of aa-tRNA. In line with this, the binding of aa-tRNA to EF-Tu.GTP is hindered by the antibiotic, as shown by the absence of a stable ternary complex and the inhibition of the enzymatic binding of aa-tRNA to the ribosome. This blocks the elongation cycle. GE2270 A does not essentially modify the intrinsic GTPase activity of EF-Tu, but impairs the stimulation by ribosomes of this reaction. The negative effect of GE2270 A on the EF-Tu.GTP interaction with aa-tRNA bears similarities with that of the structurally unrelated pulvomycin, whereas marked differences were found by comparing the effects of these two antibiotics on EF-Tu.GDP. This work emphasizes the varieties of the transitional conformations which tune the EF-Tu interaction with GTP and GDP.
Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arai K., Kawakita M., Kaziro Y. Studies on the polypeptide elongation factors from E. coli. V. Properties of various complexes containing EF-Tu and EF-Ts. J Biochem. 1974 Aug;76(2):293–306. doi: 10.1093/oxfordjournals.jbchem.a130571. [DOI] [PubMed] [Google Scholar]
- Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779–827. doi: 10.1146/annurev.bi.56.070187.004023. [DOI] [PubMed] [Google Scholar]
- Bosch L., Kraal B., Van der Meide P. H., Duisterwinkel F. J., Van Noort J. M. The elongation factor EF-Tu and its two encoding genes. Prog Nucleic Acid Res Mol Biol. 1983;30:91–126. doi: 10.1016/s0079-6603(08)60684-4. [DOI] [PubMed] [Google Scholar]
- Chinali G., Parmeggiani A. Properties of the elongation factors from Escherichia coli. Exchange of elongation factor G during elongation of polypeptide chain. Eur J Biochem. 1973 Feb 1;32(3):463–472. doi: 10.1111/j.1432-1033.1973.tb02629.x. [DOI] [PubMed] [Google Scholar]
- Cundliffe E., Thompson J. Concerning the mode of action of micrococcin upon bacterial protein synthesis. Eur J Biochem. 1981 Aug;118(1):47–52. doi: 10.1111/j.1432-1033.1981.tb05484.x. [DOI] [PubMed] [Google Scholar]
- Fasano O., Bruns W., Crechet J. B., Sander G., Parmeggiani A. Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts. Eur J Biochem. 1978 Sep 1;89(2):557–565. doi: 10.1111/j.1432-1033.1978.tb12560.x. [DOI] [PubMed] [Google Scholar]
- Gilman A. G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615–649. doi: 10.1146/annurev.bi.56.070187.003151. [DOI] [PubMed] [Google Scholar]
- Kaziro Y. The role of guanosine 5'-triphosphate in polypeptide chain elongation. Biochim Biophys Acta. 1978 Sep 21;505(1):95–127. doi: 10.1016/0304-4173(78)90009-5. [DOI] [PubMed] [Google Scholar]
- Otaka T., Kaji A. Micrococcin: acceptor-site-specific inhibitor of protein synthesis. Eur J Biochem. 1974 Dec 16;50(1):101–106. doi: 10.1111/j.1432-1033.1974.tb03876.x. [DOI] [PubMed] [Google Scholar]
- Parlato G., Guesnet J., Crechet J. B., Parmeggiani A. The GTPase activity of elongation factor Tu and the 3'-terminal end of aminoacyl-tRNA. FEBS Lett. 1981 Mar 23;125(2):257–260. doi: 10.1016/0014-5793(81)80733-8. [DOI] [PubMed] [Google Scholar]
- Parmeggiani A., Sander G. Properties and regulation of the GTPase activities of elongation factors Tu and G, and of initiation factor 2. Mol Cell Biochem. 1981 Mar 27;35(3):129–158. doi: 10.1007/BF02357085. [DOI] [PubMed] [Google Scholar]
- Parmeggiani A., Swart G. W. Mechanism of action of kirromycin-like antibiotics. Annu Rev Microbiol. 1985;39:557–577. doi: 10.1146/annurev.mi.39.100185.003013. [DOI] [PubMed] [Google Scholar]
- Parmeggiani A., Swart G. W., Mortensen K. K., Jensen M., Clark B. F., Dente L., Cortese R. Properties of a genetically engineered G domain of elongation factor Tu. Proc Natl Acad Sci U S A. 1987 May;84(10):3141–3145. doi: 10.1073/pnas.84.10.3141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pingoud A., Block W., Urbanke C., Wolf H. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli. Eur J Biochem. 1982 Apr 1;123(2):261–265. doi: 10.1111/j.1432-1033.1982.tb19762.x. [DOI] [PubMed] [Google Scholar]
- Spedding G., Cundliffe E. Identification of the altered ribosomal component responsible for resistance to micrococcin in mutants of Bacillus megaterium. Eur J Biochem. 1984 May 2;140(3):453–459. doi: 10.1111/j.1432-1033.1984.tb08124.x. [DOI] [PubMed] [Google Scholar]
- Swart G. W., Parmeggiani A., Kraal B., Bosch L. Effects of the mutation glycine-222----aspartic acid on the functions of elongation factor Tu. Biochemistry. 1987 Apr 7;26(7):2047–2054. doi: 10.1021/bi00381a038. [DOI] [PubMed] [Google Scholar]
- Wolf H., Assmann D., Fischer E. Pulvomycin, an inhibitor of protein biosynthesis preventing ternary complex formation between elongation factor Tu, GTP, and aminoacyl-tRNA. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5324–5328. doi: 10.1073/pnas.75.11.5324. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolf H., Chinali G., Parmeggiani A. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu. Proc Natl Acad Sci U S A. 1974 Dec;71(12):4910–4914. doi: 10.1073/pnas.71.12.4910. [DOI] [PMC free article] [PubMed] [Google Scholar]